Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Sirenia Capital Management LP | Institution | 9.335.000 | 8,47% | US$ 38,93M | 2026-03-31 |
| Morgan Stanley | Institution | 9.066.530 | 8,23% | US$ 37,81M | 2026-03-31 |
| Point72 Associates, LLC | Institution | 8.477.647 | 7,69% | US$ 35,35M | 2025-10-17 |
| RA Capital Management, L.P. | Institution | 8.000.000 | 7,26% | US$ 33,36M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 8.000.000 | 7,26% | US$ 33,36M | 2025-10-17 |
| Bain Capital Life Sciences Investors, LLC | Institution | 7.171.910 | 6,51% | US$ 29,91M | 2026-03-31 |
| Lynx1 Capital Management LP | Institution | 6.998.902 | 6,35% | US$ 29,19M | 2026-03-31 |
| Squadron Master Fund LP | Institution | 5.550.000 | 5,04% | US$ 23,14M | 2026-05-12 |
| Squadron Capital Management Llc | Institution | 5.550.000 | 5,04% | US$ 23,14M | 2026-05-12 |
| Betta Pharmaceuticals Co., Ltd. | Institution | 4.874.550 | 4,42% | US$ 20,33M | 2025-04-22 |
| Wasatch Advisors LP | Institution | 4.581.761 | 4,16% | US$ 19,11M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 3.861.852 | 3,51% | US$ 16,10M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 3.803.942 | 3,45% | US$ 15,86M | 2026-03-31 |
| Soleus Capital Master Fund, L.P. | Institution | 3.553.949 | 3,23% | US$ 14,82M | 2025-12-31 |
| JPMorgan Chase & Co. | Institution | 3.223.054 | 2,93% | US$ 13,44M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 3.035.634 | 2,76% | US$ 12,66M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 2.511.015 | 2,28% | US$ 10,47M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 2.461.815 | 2,23% | US$ 10,27M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 2.361.192 | 2,14% | US$ 9,85M | 2026-03-31 |
| Bank of America Corporation | Institution | 2.163.840 | 1,96% | US$ 9,02M | 2026-03-31 |
| BlackRock, Inc. | Institution | 2.048.526 | 1,86% | US$ 8,54M | 2026-03-31 |
| BCLS II Equity Opportunities, LP | Institution | 2.020.000 | 1,83% | US$ 8,42M | 2025-10-17 |
| Silverarc Capital Management, LLC | Institution | 1.911.785 | 1,74% | US$ 7,97M | 2026-03-31 |
| Acadian Asset Management LLC | Institution | 1.890.914 | 1,72% | US$ 7,89M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 1.547.119 | 1,40% | US$ 6,45M | 2026-03-31 |
| Millennium Management LLC | Institution | 1.393.342 | 1,26% | US$ 5,81M | 2026-03-31 |
| Jane Street Group, LLC | Institution | 1.246.896 | 1,13% | US$ 5,20M | 2026-03-31 |
| D. E. Shaw & Co., L.P. | Institution | 1.060.331 | 0,96% | US$ 4,42M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 951.043 | 0,86% | US$ 3,97M | 2026-03-31 |
| Wells Fargo & Company | Institution | 867.911 | 0,79% | US$ 3,62M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 856.353 | 0,78% | US$ 3,57M | 2026-03-31 |
| Congress Asset Management Company, LLP | Institution | 830.624 | 0,75% | US$ 3,46M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 752.114 | 0,68% | US$ 3,14M | 2026-03-31 |
| Mr. Bruce Downey | Insider | 489.542 | 0,44% | US$ 2,04M | 2025-04-22 |
| Vanguard Fiduciary Trust Company | Institution | 484.131 | 0,44% | US$ 2,02M | 2026-03-31 |
| Jackson National Asset Management, LLC | Institution | 471.626 | 0,43% | US$ 1,97M | 2026-03-31 |
| StemPoint Capital LP | Institution | 453.236 | 0,41% | US$ 1,89M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 452.228 | 0,41% | US$ 1,89M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 442.518 | 0,40% | US$ 1,85M | 2026-03-31 |
| L1 Group Limited | Institution | 384.766 | 0,35% | US$ 1,60M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 382.973 | 0,35% | US$ 1,60M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
